Fmoc-D-homoPhenylalanine

Fmoc-D-homoPhenylalanine is a D-configured, non-proteinogenic amino acid derivative featuring a homo-extended side chain terminated by a phenyl ring, combined with an Fmoc-protected amino group suitable for stepwise solid-phase or solution-phase peptide assembly. The molecule contains a carboxylic acid functionality and a stereogenic center at the α-carbon, enabling stereochemically defined incorporation into peptide sequences and peptidomimetic scaffolds. The Fmoc group provides orthogonal base-labile protection for the N-terminus, while the phenyl side chain supports hydrophobic and π-interaction driven recognition in structure-function studies. As a chiral amino acid building block, it can participate in standard peptide coupling chemistries and can be further transformed into downstream intermediates through side-chain functionalization or carboxyl activation strategies.

1. Peptide Synthesis

Fmoc-D-homoPhenylalanine is applied in peptide synthesis workflows where a D-amino acid and an extended, phenyl-bearing side chain are required for conformational control and resistance to proteolysis. The Fmoc-protected amine supports controlled N-deprotection and subsequent peptide coupling, while the carboxylic acid enables formation of amide bonds to incoming amino acid building blocks. The D-stereochemistry at the α-carbon allows stereodefined assembly of peptide analogs, supporting studies of backbone stereochemistry effects on folding and binding. The phenyl side chain can be used as a hydrophobic anchor in peptide construction, generating D-homoaryl substituted sequences that serve as peptide building block preparation targets for further derivatization.

2. Peptidomimetics And SAR

Fmoc-D-homoPhenylalanine is used in peptidomimetic construction and structure-activity relationship studies where side-chain length and aromatic presentation are tuned to modulate molecular recognition. The homo-phenyl architecture, with a methylene-extended linkage relative to phenylalanine, can shift spatial positioning of the aromatic ring to probe binding pocket geometry. The Fmoc-protected amino group facilitates incorporation into multi-residue analogs, enabling systematic variation of D-amino acid content while maintaining a consistent synthetic handle for sequential assembly. The resulting D-homoaryl peptide analogs can then be converted into additional derivatives for SAR mapping, including analog series designed for altered hydrophobicity, steric profile, and backbone stereochemical patterning.

3. Chiral Synthesis Intermediate

Fmoc-D-homoPhenylalanine is suitable as a chiral amino acid intermediate in synthetic organic chemistry when a D-configured, aromatic side-chain-bearing building block is required for stereoselective downstream transformations. The protected N-terminus (Fmoc) acts as a stable functional group during coupling or side-chain modification steps, while the carboxylic acid can be activated for amide formation or used to generate activated intermediates for controlled derivatization. The stereogenic center provides defined chirality for subsequent fragment elaboration, including preparation of chiral fragments used in medicinal chemistry and materials-oriented scaffold generation. The compound's combination of orthogonally protected amine and persistent aromatic functionality supports manufacturing route design for chiral fine chemical synthesis where stereochemical integrity must be maintained.

4. Chemical Biology Probes

Fmoc-D-homoPhenylalanine is employed in chemical biology research to generate peptide-based probes that incorporate D-amino acids for improved stability and distinct recognition behavior in labeling experiments. The Fmoc group enables reproducible incorporation into probe peptides, while the phenyl side chain can serve as a recognition element or a platform for further chemical modification after peptide assembly. The D-configuration can be leveraged to tune peptide conformation and reduce susceptibility to enzymatic cleavage during probe handling and incubation conditions. Downstream derivatization can include conjugation-ready peptide constructs that support biomolecular interaction mapping and analytical research applications requiring defined stereochemistry.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-homoPhenylalanine is relevant to pharmaceutical manufacturing and process chemistry contexts where protected amino acid building blocks are used to produce non-natural amino acid containing intermediates for peptide-based active ingredients or excipient-linked materials. The Fmoc protection strategy supports scalable, stepwise assembly logic by enabling controlled deprotection and coupling operations under manufacturing-compatible conditions. The presence of a carboxylic acid and an aromatic side chain allows integration into standardized peptide synthesis streams and subsequent conversion into higher-order intermediates for formulation-bound materials. The compound's defined stereochemistry and protected functional groups make it suitable for reliable intermediate preparation in specialty chemical production where reproducible peptide construction is required.

6. Side-Chain Functionalization

Fmoc-D-homoPhenylalanine is applied in side-chain functionalization programs that use the aromatic phenyl group and the extended linker to introduce new chemical handles while keeping the amino functionality protected. The Fmoc-protected amine helps maintain orthogonality during transformations that target the phenyl ring or the side-chain environment, while the carboxylic acid can be used to anchor the molecule into peptide or polymerizable frameworks. D-homoaryl substitution can be used to modulate electronic and steric properties of the resulting derivatives, supporting creation of labeled or reactive analogs for analytical research and chemical manufacturing. The resulting functionalized amino acid derivatives can be carried forward into peptide analog construction, bioconjugation-ready intermediates, or functional material synthesis where aromatic presentation and stereochemical definition are required.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate